Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:1072-1077
Published online before print May 2, 2005, doi: 10.1161/01.HYP.0000165672.69176.ed
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/6/1072    most recent
01.HYP.0000165672.69176.edv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mancia, G.
Right arrow Articles by Sega, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mancia, G.
Right arrow Articles by Sega, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Lipids
Right arrow Clinical Studies

(Hypertension. 2005;45:1072.)
© 2005 American Heart Association, Inc.


Original Articles

Relationship of Office, Home, and Ambulatory Blood Pressure to Blood Glucose and Lipid Variables in the PAMELA Population

Giuseppe Mancia; Rita Facchetti; Michele Bombelli; Hernan Polo Friz; Guido Grassi; Cristina Giannattasio; Roberto Sega

From the Istituto di Clinica Medica (G.M., R.F., M.B., H.P.F., G.G., C.G., R.S.), Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università Milano-Bicocca, Ospedale S Gerardo, Monza, Milan, Italy; Istituto Auxologico Italiano (G.M., G.G., C.G.), Milan, Italy; and Centro di Fisiologia Clinica e Ipertensione (G.M., G.G., C.G.), IRCCS, Ospedale Maggiore, Milan, Italy.

Correspondence to Professor Giuseppe Mancia, Clinica Medica, Ospedale S Gerardo, Via Donizetti 106, 20052 Monza, Milano, Italy. E-mail giuseppe.mancia{at}unimib.it

Alterations in blood glucose and cholesterol are more frequently detectable in hypertensive than in normotensive conditions. However, no information exists as to whether this phenomenon involves only office or also home and 24-hour ambulatory blood pressure (ie, when values are representative of daily life). In 2045 subjects enrolled in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study, we measured home, 24-hour, and office blood pressure. Measurements also included fasting blood glucose and serum total and HDL cholesterol values. Prevalence of diabetes (≥126 mg/dL or use of antidiabetic drugs), impaired fasting blood glucose (≥110 to <126 mg/dL), and hypercholesterolemia (serum total cholesterol ≥240 mg/dL or 200 mg/dL) increased progressively from "optimal" to "normal," "high-normal," and "elevated" office systolic or diastolic blood pressure. Fasting blood glucose and total serum cholesterol also increased progressively from the first to the fourth group, with HDL cholesterol values showing a concomitant progressive decrease. This was also the case for quartiles of office, home, and 24-hour blood pressure. In the whole population, there was a positive correlation between serum cholesterol or blood glucose and all blood pressure values (P always <0.0001), with a much smaller and less consistent relationship with heart rate. In a multivariate analysis that included gender, body mass index, age, and antihypertensive treatment, all blood pressure values remained highly significantly related to values of either metabolic variables. Thus, in the PAMELA population, glucose and lipid values are independently related to blood pressure. This is also the case when daily life blood pressure values are considered.


Key Words: blood pressure monitoring, ambulatory • cholesterol • glucose • lipids




This article has been cited by other articles:


Home page
Diabetes CareHome page
A. Leibowitz and E. Grossman
How to Define Prehypertension in Diabetes/Metabolic Syndrome
Diabetes Care, November 1, 2009; 32(suppl_2): S275 - S279.
[Full Text] [PDF]


Home page
Diabetes CareHome page
M. Bursztyn and I. Z. Ben-Dov
White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
Diabetes Care, November 1, 2009; 32(suppl_2): S310 - S313.
[Full Text] [PDF]


Home page
HypertensionHome page
T. W. Hansen, L. Thijs, J. Boggia, Y. Li, M. Kikuya, K. Bjorklund-Bodegard, T. Richart, T. Ohkubo, J. Jeppesen, C. Torp-Pedersen, et al.
Prognostic Value of Ambulatory Heart Rate Revisited in 6928 Subjects From 6 Populations
Hypertension, August 1, 2008; 52(2): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al.
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur. Heart J., June 11, 2007; (2007) ehm236v1.
[Full Text] [PDF]


Home page
HypertensionHome page
G. Mancia, R. Facchetti, M. Bombelli, G. Grassi, and R. Sega
Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure
Hypertension, May 1, 2006; 47(5): 846 - 853.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Bursztyn
Out-of-Office Blood Pressure Measurement: A New Era
Hypertension, June 1, 2005; 45(6): 1070 - 1071.
[Full Text] [PDF]